About

Market intelligence you can check

Accelerator Bio builds market intelligence for life-science and therapeutics companies. Every count, ranking and claim traces back to a primary record: a trial registration, an FDA approval, a grant, a filing or a paper.

What we do

Atlases. Interactive maps of a field: who runs which trials where, which companies partner with whom, what has been approved, and which methods and tools labs actually use. Available atlases: cell therapy and AI in life science.

Intelligence engine. The connected record behind the atlases (trials, companies, deals, papers, funding), offered by invitation for teams that want to query it directly, with sources attached. We can also build a knowledge base exclusive to you: your in-house and proprietary data combined with the public record, so your team develops insights no one else has. Built for your internal questions:

• R&D plans
• Market intelligence and product positioning
• Customer mapping
• Where the field is moving: market and scientific trends

Your data stays yours, private to your team and never added to the public atlases.

Public examples: our field atlases for cell therapy and AI in life science.

Advisory. For tools, diagnostics and therapeutics teams: product and commercial strategy, R&D decisions, market landscapes, competitive and acquirer analysis, positioning, and launch plans, built on the data rather than opinion.

Custom builds. We have built custom knowledge bases, APIs, MCP servers (connectors that let AI assistants query your data), dashboards, reports and automations, shaped around your data and how your team works.

How we work

We collect data directly from primary sources, such as clinical trial registries, primary literature, regulatory approvals, grants and public filings, and only through approved channels: official APIs, open-source datasets, or data agreements.

• Primary sources first. ClinicalTrials.gov, the FDA, NIH RePORTER, CORDIS, UKRI, SEC EDGAR, Europe PMC and PubMed, and company announcements.
• Receipts on every line. Each record links to where it came from, so a number can be checked in one click and quoted with confidence.
• Counts are floors, not guesses. Records are merged by narrow, documented rules, and unknown fields are left blank rather than estimated. Where we make an assumption, we state its basis, so it is always clear what is grounded in a record and what is an extrapolation.
• Tool and model agnostic. We integrate with the tools your team already uses and work across AI models from OpenAI, Anthropic, Google, Microsoft, xAI and more, as well as specialist biology models, choosing the right one for each question.

Who is behind it

Accelerator Bio is led by Abe Couse, who spent his career launching and marketing life-science products. He now builds the evidence layer to inform those decisions, and the team uses it with clients on landscapes, positioning, partnering and launch for life-science tools and therapeutics companies.

Contact

We've worked with life-science tools, reagent and therapeutics companies on product and commercial strategy, R&D decisions, market landscapes, competitive analysis and launch planning. Bring us a question you need answered or a decision you're facing, and we'll build the analysis around it.

Connect on LinkedIn, or request access to an atlas and mention what you are working on.